Eli Lilly has just released positive Phase III trial results for its experimental oral GLP-1 drug, orforglipron.
People taking the drug experienced substantial improvements in weight loss and blood sugar control compared to those taking a placebo. It appeared to be as safe and tolerable as other existing GLP-1 drugs.
The company now plans to apply for approval from the Food and Drug Administration, with a decision expected next year.
Read the article on Gizmodo.com.
Sources:
• TLDR. (2025, August 27). TLDR Newsletter. https://a.tldrnewsletter.com/web-version?ep=1&lc=f5cb7e17-003d-11ed-9258-0241b9615763&p=41701170-831b-11f0-bf56-93510d7df097&pt=campaign&t=1756292128&s=e2ed24f72a6f60f6c10a1fd8616a8728c159036b38a399e058711e2f57498c0e
• Cara, E. (2025, August 26). A pill to fight obesity is on the verge of approval. Gizmodo. https://gizmodo.com/a-pill-to-fight-obesity-is-on-the-verge-of-approval-2000648312
